Hold onto your hats, Braves fans – the team's just locked in a familiar face who could swing the bullpen dynamics in 2026! Danny Young, that reliable left-handed reliever, is back in Atlanta on a one-year major league deal, stirring up excitement and a few debates about smart roster moves. But here's where it gets intriguing: this isn't just any signing; it's a reunion with old pals and a gamble on recovery that might pay off big time. Let's dive into the details and unpack what this means for the Braves' pitching staff, shall we?
The Braves made the announcement bright and early Tuesday, confirming they've inked Young to that one-year pact. For those new to baseball jargon, this is a 'split deal' – basically, he gets paid different amounts depending on where he's playing. At $925,000 for major league gigs and a lower rate in the minors, it's designed to fit the team's budget while giving Young a chance to shine. Represented by the Dynamic Sports Group, he's now officially part of Atlanta's 40-man roster, a key spot that protects him from being picked up by other teams without consent. MLBTR scooped the salary scoop from a reliable source, highlighting how this setup keeps things flexible for both sides.
This marks Young's second go-around with the Braves, building on his 2023 stint where he dazzled in the big leagues with 8 1/3 innings of solid work, though he hit some bumps in the minors over 15 2/3 frames. Injuries played a big role back then, and they'll factor in again next year too. After two strong seasons pitching out of the Mets' bullpen, Young underwent Tommy John surgery last May – that's a procedure to repair a torn ulnar collateral ligament in the elbow, common among pitchers and often requiring a lengthy rehab to get back to full strength. By joining the Braves, he's reuniting with Jeremy Hefner, the pitching coach who guided him in New York and has since moved to Atlanta. Imagine the comfort of that familiar voice calling the shots – it could be a real boost during recovery!
Young will kick off the 2026 season on the injured list as he wraps up rehab from that surgery. According to an insider, he's already started throwing last month, with hopes of returning to live action before the All-Star break. For beginners, the injured list is like a timeout for players recovering from injuries, allowing teams to keep them on the roster without them taking up a spot in the lineup. This timeline suggests the Braves are optimistic about his comeback, but it's not without risks – surgery recoveries can be unpredictable, and rushing back might lead to setbacks.
Over his four-part major league career, Young has racked up 60 2/3 innings, posting a 4.01 earned run average. But here's the part most people miss: his underlying stats tell a different story, painting him as a potentially elite performer. With a whopping 29% strikeout rate, a low 9.3% walk rate, and a 53.3% ground-ball rate, he's got the stuff to dominate hitters. Advanced metrics like SIERA (at 3.02) and FIP (at 3.23) – which adjust for things like luck on balls in play or defense – suggest he's been much better than his ERA shows. That bloated .344 average on balls in play? It's basically a measure of how many hits he's allowed that could have been outs, and it doesn't reflect his true talent. Think of it like a pitcher who throws strikes but faces tough luck – these numbers hint at hidden value, and if he can keep the ball on the ground and rack up Ks, he could become a bullpen staple.
Once spring training rolls around, the Braves will likely shift Young to the 60-day injured list to free up a 40-man spot. If they need that spot sooner, they might put him through waivers – a process where other teams can claim him, though his salary terms could make him unattractive and keep him in Atlanta. And this is the part that sparks debate: Young could reject an outright assignment to the minors in favor of free agency, but doing so means walking away from the guaranteed cash tied to his rates. Is this a savvy way for the team to retain talent without overpaying, or a risky bet on a pitcher who's still rehabbing? Opinions might differ, but it underscores the strategic chess game of roster management.
If Young remains on the 40-man or 60-day IL until he's activated, he'll add another left-handed option to a bullpen already boasting Dylan Lee and Aaron Bummer. Plus, out-of-options lefties like Dylan Dodd and Joey Wentz are lined up for roles, creating a crowded but talented southpaw squad. For context, being 'out of options' means a player can't be sent back to the minors without going through waivers, making them more likely to stick in the majors.
Looking ahead, if Young rebounds strongly, he could evolve into a key long-term asset for Atlanta's relief crew. With just 1.160 years of major league service under his belt, the Braves have control over him through 2030 – that's five more seasons of potential dominance. Sure, it's a ways off, but slapping him right onto the 40-man roster signals the team's willingness to integrate him beyond 2026 if he delivers. Notably, Bummer hits free agency after next year, opening doors for Young to step up. But here's where it gets controversial: in a sport obsessed with young arms and high-stakes acquisitions, is betting on a rehabbing veteran like Young worth the gamble, especially when he might not fully recover? Some might argue it's a smart, cost-effective move; others could see it as a potential drain on resources if things don't click.
What do you think, fans? Is this signing a masterstroke for the Braves' future, or just another risky roll of the dice? Do you believe Young's stats point to untapped potential, or is the injury history a red flag? Share your takes in the comments below – I'm curious to hear your thoughts!
View Comments (6)
